PRImus-AD met its primary safety endpoint, with PRI-002 demonstrating a favorable safety and tolerability profile The study did not meet its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results